Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate.
Sun Z, Chu X, Adams C, Ilina TV, Guerrero M, Lin G, Chen C, Jelev D, Ishima R, Li W, Mellors JW, Calero G, Dimitrov DS.
Sun Z, et al. Among authors: ilina tv.
Mol Ther Oncolytics. 2023 Sep 13;31:100726. doi: 10.1016/j.omto.2023.09.002. eCollection 2023 Dec 19.
Mol Ther Oncolytics. 2023.
PMID: 37771390
Free PMC article.